One study showed that LURAP1L was among genes with altered gene expression in lung tissue of deceased COVID-19 patients that could be targeted with the anti-inflammatory activities of glucocorticoid drugs (Sharma, 2021). The gene discussed is LURAP1L; the disease is COVID-19.